[Potassium-magnesium-aspartate therapy in operated cancer patients].
D000328:Adult; D000368:Aged; D000747:Anemia, Hypochromic / Q000188:drug therapy*; D001224:Aspartic Acid / Q000378:metabolism / Q000627:therapeutic use*; D001835:Body Weight; D001943:Breast Neoplasms / Q000601:surgery; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007656:Ketoglutaric Acids / Q000097:blood; D008134:Long-Term Care; D008274:Magnesium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000601:surgery; D011182:Postoperative Care; D011188:Potassium / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000601:surgery; D012046:Rehabilitation; D012186:Retroperitoneal Neoplasms / Q000601:surgery; D013274:Stomach Neoplasms / Q000601:surgery; D013964:Thyroid Neoplasms / Q000601:surgery; D014062:Tongue Neoplasms / Q000601:surgery
D007656:Ketoglutaric Acids; D001224:Aspartic Acid; D008274:Magnesium; D011188:Potassium
Kalium-Magnesium-Aspartat-Behandlung bei operierten Karzinompatienten.